title: Molecular and functional characterization of human pendrin and its allelic variants.
abstract: Pendrin (SLC26A4, PDS) is an electroneutral anion exchanger transporting I(-), Cl(-), HCO(3)(-), OH(-), SCN(-) and formate. In the thyroid, pendrin is expressed at the apical membrane of the follicular epithelium and may be involved in mediating apical iodide efflux into the follicle; in the inner ear, it plays a crucial role in the conditioning of the pH and ion composition of the endolymph; in the kidney, it may exert a role in pH homeostasis and regulation of blood pressure. Mutations of the pendrin gene can lead to syndromic and non-syndromic hearing loss with EVA (enlarged vestibular aqueduct). Functional tests of mutated pendrin allelic variants found in patients with Pendred syndrome or non-syndromic EVA (ns-EVA) revealed that the pathological phenotype is due to the reduction or loss of function of the ion transport activity. The diagnosis of Pendred syndrome and ns-EVA can be difficult because of the presence of phenocopies of Pendred syndrome and benign polymorphisms occurring in the general population. As a consequence, defining whether or not an allelic variant is pathogenic is crucial. Recently, we found that the two parameters used so far to assess the pathogenic potential of a mutation, i.e. low incidence in the control population, and substitution of evolutionary conserved amino acids, are not always reliable for predicting the functionality of pendrin allelic variants; actually, we identified mutations occurring with the same frequency in the cohort of hearing impaired patients and in the control group of normal hearing individuals. Moreover, we identified functional polymorphisms affecting highly conserved amino acids. As a general rule however, we observed a complete loss of function for all truncations and amino acid substitutions involving a proline. In this view, clinical and radiological studies should be combined with genetic and molecular studies for a definitive diagnosis. In performing genetic studies, the possibility that the mutation could affect regions other than the pendrin coding region, such as its promoter region and/or the coding regions of functionally related genes (FOXI1, KCNJ10), should be taken into account. The presence of benign polymorphisms in the population suggests that genetic studies should be corroborated by functional studies; in this context, the existence of hypo-functional variants and possible differences between the I(-)/Cl(-) and Cl(-)/HCO(3)(-) exchange activities should be carefully evaluated.
authors: Institute of Pharmacology and Toxicology, Paracelsus Medical University, Salzburg, Austria. silvia.dossena@pmu.ac.at
authors: Silvia
authors: S
authors: Dossena
authors: Charity
authors: C
authors: Nofziger
authors: Grazia
authors: G
authors: Tamma
authors: Emanuele
authors: E
authors: Bernardinelli
authors: Simone
authors: S
authors: Vanoni
authors: Christoph
authors: C
authors: Nowak
authors: Elisabeth
authors: E
authors: Grabmayer
authors: Sonja
authors: S
authors: Kössler
authors: Susanne
authors: S
authors: Stephan
authors: Wolfgang
authors: W
authors: Patsch
authors: Markus
authors: M
authors: Paulmichl
mesh_terms: D000483:Alleles; D000838:Anions / Q000378:metabolism; D006044:Goiter, Nodular / Q000235:genetics / Q000473:pathology; D006319:Hearing Loss, Sensorineural / Q000235:genetics / Q000473:pathology; D006801:Humans; D017136:Ion Transport; D026901:Membrane Transport Proteins / Q000235:genetics* / Q000378:metabolism*; D009154:Mutation; D020641:Polymorphism, Single Nucleotide; D000076988:Sulfate Transporters; D014723:Vestibular Aqueduct / Q000502:physiology
chemical_list: D000838:Anions; D026901:Membrane Transport Proteins; C085609:SLC26A4 protein, human; D000076988:Sulfate Transporters